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Is Counseling Integral to Buprenorphine-Assisted Opioid Addiction Treatment? 
Examining Counseling Participation and Treatment Retention at a Richmond, VA Clinic
John R. Gyourko & H. Colin King
Virginia Commonwealth University School of Social Work, Richmond, VA
Buprenorphine, a medication often marketed under the brand name
Suboxone, is a popular treatment for opioid use disorder (OUD).
Federal and state regulations require clinics to provide counseling
services or referrals to clients receiving buprenorphine-assisted
OUD treatment1.
Prescribing physicians widely regard counseling as a critical
component of buprenorphine treatment2, and individuals with OUD
perceive counseling to be among the most important factors
supporting recovery3.
Nearly all U.S. clinics offering buprenorphine-assisted OUD
treatment also offer individual or group counseling services4.
Research investigating the efficacy of counseling as an OUD
treatment component, however, has been equivocal to date5,6.
Additional research is needed to evaluate the comparative benefits
of counseling across varying clinical contexts.
Aim
To investigate the effects of counseling on treatment retention
among clients receiving OUD treatment at the VCU Multidisciplinary
Outpatient Intensive Addiction Treatment (MOTIVATE) clinic.
Instrument
MOTIVATE clinic developed a non-standardized semi-structured
survey which was administered in Nov. 2018 to a convenience
sample of 81 clinic clients.
A secondary data set was compiled by parsing completed surveys
according to responses concerning opioid type, treatment
medication, and counseling participation.
Population
71 clients receiving buprenorphine-assisted OUD treatment
49% African American  / 37% White  / 3% Native American
Mean age = 45
61% female
Methods
Counseling type
Effect on treatment length for clients in treatment <12 months 
(p=.019)
Median treatment length higher for clients in group and 
concurrent counseling vs. individual counseling
Counseling frequency
Group frequency affected treatment length for clients in 
treatment <12 months (p=.002)
Individual frequency affected treatment length for clients in 
treatment ≥12 months (p=.046)
Total counseling frequency affected treatment length (p=.006)
Counseling type and frequency appear to have stronger effects on
retention among newer clients. Findings indicate that the
comparative benefits of counseling depend in part on client
treatment phase. While this study corroborates the importance of
psychosocial interventions for clients in buprenorphine-assisted
OUD treatment, results suggest the need for a nuanced approach
to client education and treatment planning.
Policy & Practice Implications
Understanding the relationships between counseling type, 
frequency, and treatment length may empower clients toward 
better-individualized treatment plans
Results support previous research indicating that voluntary, 
individualized counseling recommendations based on 
treatment phase and client history are most beneficial7
Limitations
Use of secondary data set restricted control over research 
design and inhibited exploration of potential mediating, 
moderating, and/or intervening variables
Convenience sampling & small sample size
Cross-sectional, nonexperimental design
Future Research
Counseling dynamics (group size, group cohesion, open vs. 
closed types, client-clinician interactions)
Standardized survey instrument
Background Results Discussion
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